CDK6 and AL amyloidosis: Here, we apply quantitative proteomic analyses in paired, longitudinal primary multiple myeloma samples and identify CDK6 upregulation as a non-genetic resistance mechansim for IMiDs in multiple myeloma that can be overcome by pharmacologic intervention.